North America Syndromic Multiplex Diagnostic Market survey report covers myriad of aspects of the market analysis which many businesses call for. The data and information is extensively researched and analyzed in the report to guide market players to improve their business planning and ensure long-term success. To a.
Applied BioCode announced today that Beth Laderman has been appointed as their new Chief Scientific Officer signaling a significant step in the company’s expansion. With 25 years of experience in.
Global Syndromic Multiplex Diagnostic Market report highlights all-inclusive professional study of the HELATH industry which focuses on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis. This global market research report is a professional and a detailed rep.
Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States
U.S. Distribution of the Automated High Throughput Multiplex Molecular. | May 8, 2023
Hardy Diagnostics will begin offering Applied BioCode's MDx-3000 molecular diagnostic system, tests, and analyte specific reagents to US hospitals and reference laboratories.